ImaginAB Licenses UCLA Technology
socalTECH
APRIL 18, 2011
Los Angeles-based ImaginAb , a biotechnology firm spun out by UCLA faculty members, announced this morning that it has concluded a technology licensing agreement with the school. ImaginAb said it now has exclusivity to the technology for antibodies and antibody fragments. Financial details of the license were not disclosed.
Let's personalize your content